Epstein-Barr virus suppresses N6-methyladenosine modification of TLR9 to promote immune evasion
Authors:
- Xiaoyue ZhangXZXiaoyue Zhang
- Zhengshuo LiZLZhengshuo Li
- Qiu PengQPQiu Peng
- Can LiuCLCan Liu
- Yangge WuYWYangge Wu
- Yuqing WenYWYuqing Wen
- Run ZhengRZRun Zheng
- Chenxiao XuCXChenxiao Xu
- Junrui TianJTJunrui Tian
- Jia WangJWJia Wang
Open Access
- 25 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (5) , 107226
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 82 references indexed in Scilit:
- Epstein-Barr virus: Biology and clinical diseaseCell, 2022
- ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3Cancer Letters, 2022
- RNA m6A methylation regulates virus–host interaction and EBNA2 expression during Epstein–Barr virus infectionImmunity, Inflammation and Disease, 2021
- RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6‐methyladenosine (m6A)Reviews in Medical Virology, 2018
- HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing EventsCell, 2015
- N6-methyladenosine Modulates Messenger RNA Translation EfficiencyCell, 2015
- Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ SitesCell Reports, 2014
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Expression of TLR9 within human glioblastomaJournal of Neuro-Oncology, 2008
- Epstein‐Barr virus‐associated complement‐fixing and nuclear antigens in Burkitt lymphoma biopsiesInternational Journal of Cancer, 1974